MS4A1 and non-Hodgkin lymphoma: The occurence of CD20 negativity in patients with follicular lymphoma at the follow-up is relatively consistent with results from patients with non-Hodgkin lymphoma, ranging from 12% of patients in Foran’s study[13] and 26% of patients in Hiraga’s study[5].